Psychedelics for Borderline

Though not studied nearly enough, some psychedelics (mainly ketamine) are being researched to help those with borderline. One trial is ongoing to study the effects of psilocybin on borderline that co-occurs with depression.

This topic is currently a stub, it will be expanded upon in the near future.

Highlighted Institutes

These are the institutes, from companies to universities, who are working on Borderline.

Highlighted People

These are some of the best-known people, from researchers to entrepreneurs, working on Borderline.

Linked Research Papers & Trials

Pro & Business members will be able to see all linked papers and trials directly on this topic page.

This information is still available for you by selecting Borderline on the Papers and Trials pages respectively.

See the information directly on this page with a paid membership.

The Bloom

Sign up for weekly updates about psychedelics
📰 3x latest research papers
📣 2x new articles & commentary
🎤 1x updates on events & courses

Made Possible by Members

This topic page is made possible by the generous contributions of our paying members. Their donations allow us to spend time explaining psychedelic research so you can stay informed in an instant.

Become a supporting member!

Topic Information

124 million people affected worldwide¹

Borderline personality disorder causes significant impairment and distress and is associated with multiple medical and psychiatric co-morbidities.

Current Treatments¹

Treatment for borderline personality disorder currently consists of psychotherapy and can include medication. Several talk therapy methods such as dialectical behaviour therapy and schema-focused therapy can be used. There is no medication approved for borderline, but this can be given for co-morbid depression or other disorders.

Psychedelic research currently is in Phase IIa

Only one trial with psychedelics has recently started. This trial will look at psilocybin for borderline in combination with depression. Anecdotal evidence points towards positive effects of psychedelices.